Quick Answer
MEDICINOVA INC reported Diluted EPS of $0.24 per share (loss) for fiscal year 2025.
MEDICINOVA INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.24 | -4.3% |
| 2024 | -$0.23 | -35.3% |
| 2023 | -$0.17 | +41.4% |
| 2022 | -$0.29 | -38.1% |
| 2021 | -$0.21 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.06 | +0.0% | +14.3% |
| June 30, 2025 | -$0.07 | -40.0% | -16.7% |
| March 31, 2025 | -$0.06 | +0.0% | +0.0% |
| September 30, 2024 | -$0.06 | -500.0% | -20.0% |
| June 30, 2024 | -$0.05 | +16.7% | +16.7% |
| March 31, 2024 | -$0.06 | +0.0% | -500.0% |
| September 30, 2023 | -$0.01 | +85.7% | +83.3% |
| June 30, 2023 | -$0.06 | +25.0% | +0.0% |
- MEDICINOVA INC showed a decrease of -4.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, MEDICINOVA INC’s diluted eps has declined by 14.3% (from $0.21 per share (loss) to $0.24 per share (loss)).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: